BRIDGEWAY CAPITAL MANAGEMENT, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 120 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$641,736
+32.7%
594,200
+58.5%
0.02%
+33.3%
Q2 2023$483,750
+41.0%
375,000
+44.2%
0.01%
+33.3%
Q1 2023$343,200
-29.6%
260,000
-20.0%
0.01%
-30.8%
Q4 2022$487,500
+27.0%
325,0000.0%0.01%
+30.0%
Q3 2022$384,000
-4.2%
325,000
+106.0%
0.01%
+100.0%
Q3 2017$401,000
-7.0%
157,8000.0%0.01%0.0%
Q2 2017$431,000
-17.4%
157,8000.0%0.01%
-16.7%
Q1 2017$522,000
+38.8%
157,8000.0%0.01%
+20.0%
Q4 2016$376,000
-48.2%
157,800
-20.2%
0.01%
-54.5%
Q3 2016$726,000
+71.2%
197,800
+4.1%
0.01%
+57.1%
Q2 2016$424,000
+7.3%
190,0000.0%0.01%0.0%
Q1 2016$395,000
-33.3%
190,000
-2.7%
0.01%
-36.4%
Q4 2015$592,000
+3.3%
195,300
-15.7%
0.01%
-8.3%
Q3 2015$573,000
-8.6%
231,800
+18.7%
0.01%0.0%
Q2 2015$627,000
-11.1%
195,300
-1.2%
0.01%
-20.0%
Q1 2015$705,000
+57.0%
197,6000.0%0.02%
+50.0%
Q4 2014$449,000
-20.8%
197,600
-32.4%
0.01%
-28.6%
Q3 2014$567,000
-43.4%
292,500
+5.9%
0.01%
-46.2%
Q2 2014$1,002,000
+80.2%
276,100
+92.5%
0.03%
+62.5%
Q1 2014$556,000143,4000.02%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders